A pilot study of epratuzumab and rituximab in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy in patients with previously untreated, diffuse large B-cell lymphoma. [electronic resource]
Producer: 20070212Description: 2826-32 p. digitalISSN:- 0008-543X
- Adult
- Aged
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Humanized
- Antibodies, Monoclonal, Murine-Derived
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Cyclophosphamide -- therapeutic use
- Disease-Free Survival
- Doxorubicin -- therapeutic use
- Female
- Humans
- Lymphoma, B-Cell -- drug therapy
- Lymphoma, Large B-Cell, Diffuse -- drug therapy
- Male
- Middle Aged
- Pilot Projects
- Prednisone -- therapeutic use
- Rituximab
- Treatment Outcome
- Vincristine -- therapeutic use
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.